Anti-arrythmic drugs
A knowledgeable insight on Anti-arrythmic drugs
Antiarrhythmic drugs are used to prevent, control, or terminate cardiac arrhythmias by modifying cardiac electrical activity. They are commonly classified according to the Vaughan Williams classification.
Class I – Sodium Channel Blockers
IA: Quinidine, Procainamide – moderate Na⁺ channel blockade, prolong action potential
IB: Lidocaine, Mexiletine – weak blockade, shorten action potential
IC: Flecainide, Propafenone – strong blockade, minimal effect on action potential
Class II – Beta-Adrenergic Blockers
Propranolol, Metoprolol, Atenolol
Reduce sympathetic stimulation and AV nodal conduction
Class III – Potassium Channel Blockers
Amiodarone, Sotalol, Dofetilide
Prolonged repolarization and refractory period
Class IV – Calcium Channel Blockers
Verapamil, Diltiazem
Decrease AV nodal conduction and heart rate
Others
Adenosine, Digoxin, Magnesium sulfate
From a dental perspective, awareness of drug interactions, risk of bradycardia or hypotension, and stress reduction during treatment is essential.